DeutschNewstral
Article
bizjournals.com on 2017-10-05 20:34
Durham pharma banks $25M+ from Duke University spinout
Related news
- Duke spinout raises $25M to advance genome editing techniquebizjournals.com
- Duke spinout Aerie signs deal to help develop eye treatmentsbizjournals.com
- Duke University spinout Bright View Technologies doubles manufacturing spacebizjournals.com
- On heels of $25M+ deal, Aerie beefing up in Durhambizjournals.com
Pedestrian hit, killed near Duke University in DurhamWRAL- Driver charged in Durham crash that killed Duke workerWRAL
- Duke University spinout tests eye treatment in late stage trialbizjournals.com
- Durham pharma embarks on $275M financial tradebizjournals.com
- Japanese pharma sues Durham drug developerbizjournals.com
- Stem cell firm that partners with Duke University grabs space in Durhambizjournals.com
- Pedestrian dies after being hit by two vehicles near Duke University in DurhamWRAL
- Microsoft partnering with Duke in downtown Durhambizjournals.com
- Does race play a role in the justice system? Duke researchers study plea deals in Durham CountyWRAL
- Duke spinout loses $600M of market value, 72% of the company valuebizjournals.com
- Months after $100M raise, budding RTP firm acquires Duke University spinoutbizjournals.com
- Durham pharma to add manufacturing, ramp up hiringbizjournals.com
- Durham pharma solutions firm taps new president from withinbizjournals.com
- Avista Pharma CEO talks lab expansion at Durham HQbizjournals.com
- Durham pharma startup closes $15M-plus round with Japanese investorbizjournals.com
- Durham pharma buys building for new headquarters operationsbizjournals.com